INVERIME
Honduras
Efficacy and Safety of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescent Aged 9 to 16 years in Latin America. SanofiPasteur CYD 15 Protocol.
Immunogenicity and Safety ...
- Size Single investigators
- Previous clinical trials None
- Staff 17